Table 2.
Comparing the number of patients free of zoster pain in both the study groups at each follow-up
Days | Valacyclovir, n (%) | Famciclovir, n (%) | P* |
---|---|---|---|
3 | 0 | 0 | - |
8 | 6 (20) | 6 (20) | 1.000 |
15 | 16 (53.34) | 14 (47) | 0.7963 |
22 | 18 (60) | 16 (53.34) | 0.7945 |
29 | 24 (80) | 18 (60) | 0.1590 |
*P<0.05 significant